Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 6;5(1):24.
doi: 10.1186/s41687-021-00301-5.

Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study

Adriane Kamulegeya  1 , Damalie Nakanjako  2 , Jackson Orem  3 , Harriet Mayanja-Kizza  2
Affiliations

Experiences of patients who developed oral mucositis during solid neoplasms treatment: a Ugandan qualitative study

Adriane Kamulegeya et al. J Patient Rep Outcomes. .

Abstract

Background: Research on the management of complications of chemotherapy is important in facilitating the growing approaches to individualized patient management. Hence the need to document patient's perspectives about chemotherapy-induced mucositis and the support they need from cancer care teams.

Methods: We carried out a qualitative study using in-depth interviews (IDI) and focus group discussions (FGD). We collected patient's experiences on chemotherapy-induced mucositis by conducting 5 FGD and 13 IDIs.

Results: One glaring improvement that we need to make is the provision of information and counseling before, during, and after chemotherapy. Additionally, we need to explore inexpensive mucositis preventive strategies to aid our patients as they undergo treatment.

Conclusion: As a country, we must move away from taking cancer patients' needs as those of common tropical diseases. This will allow us to provide that extra help needed outside the usual diagnosis and administration of medication.

Keywords: Cancer; Chemotherapy side effects; Oral mucositis.

PubMed Disclaimer

Conflict of interest statement

We have no competing interests.

References

    1. Corrie PG. Cytotoxic chemotherapy : Clinical aspects. Medicine (Baltimore) 2019;36(1):24–28. doi: 10.1016/j.mpmed.2007.10.012. - DOI
    1. Sonis BST, Fey EG. Oral complications of cancer therapy. Oncology. 2002;16:680–695. - PubMed
    1. Maree JE, Combrink MJ, de Lange T, Toerien AS, Bedeker M. Incidence, severity, and management of cancer chemotherapy-related oral mucositis in eastern cape and Western cape. Heal SA. 2012;17(1):632 1–632 7.
    1. Peterson DE, Bensadoun RJ, Roila F, O. behalf of the E. guidelines working Group Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Annals of Oncology. 2010;20(Supplement 4):v261–v265. doi: 10.1093/annonc/mdq197. - DOI - PubMed
    1. D’Hondt L, Christophe L, Marc A, Jean-Luc C. Oral mucositis induced by anticancer treatments : Physiopathology and treatments. Therapeutics and Clinical Risk Management. 2006;2(2):159–168. doi: 10.2147/tcrm.2006.2.2.159. - DOI - PMC - PubMed

LinkOut - more resources